Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013

NEW YORK, Aug. 26, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013

http://www.reportlinker.com/p01600259/Pre-Diabetes/Impaired-Glucose-Tolerance-Global-Clinical-Trials-Review-H2-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013

Summary GlobalData's clinical trial report, "Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013" provides data on the Pre-Diabetes/Impaired Glucose Tolerance clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Pre-Diabetes/Impaired Glucose Tolerance. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Pre-Diabetes/Impaired Glucose Tolerance. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more- Obtain discontinued trial listing for trials across the globe- Espy the commercial landscape of the major Universities / Institutes / Hospitals or CompaniesTable of ContentsTable of Contents 2List of Tables 5List of Figures 7Introduction 8Pre-Diabetes/Impaired Glucose Tolerance 8Report Guidance 8Clinical Trials by Region 9Clinical Trials by Country 10Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12Top Five Countries Contributing to Clinical Trials in Europe 13Top Countries Contributing to Clinical Trials in North America 14Top Countries Contributing to Clinical Trials in Middle East and Africa 15Top Five Countries Contributing to Clinical Trials in Central and South America 16Clinical Trials by BRIC Nations 17Clinical Trials by G7 Nations 18Clinical Trials in G7 Nations by Trial Status 19Clinical Trials by E7 Nations 20Clinical Trials in E7 Nations by Trial Status 21Clinical Trials by Phase 22In Progress Trials by Phase 23Clinical Trials by Trial Status 24Unaccomplished Trials of Pre-Diabetes/Impaired Glucose Tolerance 25Subjects Recruited Over a Period of Time 29Prominent Sponsors 30Top Companies Participating in Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials 32Prominent Drug Comparison 34Clinical Trial Profiles 35Clinical Trial Overview of Top Companies 35Novartis AG 35Clinical Trial Overview of Novartis AG 35Genfit SA 36Clinical Trial Overview of Genfit SA 36Sanofi 37Clinical Trial Overview of Sanofi 37Novo Nordisk A/S 38Clinical Trial Overview of Novo Nordisk A/S 38Merck & Co., Inc. 39Clinical Trial Overview of Merck & Co., Inc. 39Generex Biotechnology Corporation 40Clinical Trial Overview of Generex Biotechnology Corporation 40Limerick BioPharma, Inc. 41Clinical Trial Overview of Limerick BioPharma, Inc. 41NuMe Health LLC 42Clinical Trial Overview of NuMe Health LLC 42KineMed, Inc. 43Clinical Trial Overview of KineMed, Inc. 43Arete Therapeutics Inc. 44Clinical Trial Overview of Arete Therapeutics Inc. 44New Chapter, Inc. 45Clinical Trial Overview of New Chapter, Inc. 45Cadila Pharmaceuticals Ltd. 46Clinical Trial Overview of Cadila Pharmaceuticals Ltd. 46Resverlogix Corp. 47Clinical Trial Overview of Resverlogix Corp. 47Bayer AG 48Clinical Trial Overview of Bayer AG 48UnitedHealth Group Incorporated 49Clinical Trial Overview of UnitedHealth Group Incorporated 49Marico Limited 50Clinical Trial Overview of Marico Limited 50Forest Laboratories, Inc. 51Clinical Trial Overview of Forest Laboratories, Inc. 51Takeda Pharmaceutical Company Limited 52Clinical Trial Overview of Takeda Pharmaceutical Company Limited 52Bioneer Corporation 53Clinical Trial Overview of Bioneer Corporation 53Daiichi Sankyo Company, Limited 54Clinical Trial Overview of Daiichi Sankyo Company, Limited 54Clinical Trial Overview of Top Institutes / Government 55The National Institute of Diabetes and Digestive and Kidney Diseases 55Clinical Trial Overview of The National Institute of Diabetes and Digestive and Kidney Diseases 55U.S. Department of Veterans Affairs 56Clinical Trial Overview of U.S. Department of Veterans Affairs 56Yale University 57Clinical Trial Overview of Yale University 57University of Toronto 58Clinical Trial Overview of University of Toronto 58University of Eastern Finland 59Clinical Trial Overview of University of Eastern Finland 59Maastricht University Medical Center 60Clinical Trial Overview of Maastricht University Medical Center 60University of Leipzig 61Clinical Trial Overview of University of Leipzig 61National Taiwan University Hospital 62Clinical Trial Overview of National Taiwan University Hospital 62Eunice Kennedy Shriver National Institute of Child Health and Human Development 63Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 63Pennington Biomedical Research Foundation 64Clinical Trial Overview of Pennington Biomedical Research Foundation 64Mayo Clinic 65Clinical Trial Overview of Mayo Clinic 65University of Minnesota 66Clinical Trial Overview of University of Minnesota 66Duke University 67Clinical Trial Overview of Duke University 67Stanford University 68Clinical Trial Overview of Stanford University 68Beth Israel Deaconess Medical Center 69Clinical Trial Overview of Beth Israel Deaconess Medical Center 69Chinese University of Hong Kong 70Clinical Trial Overview of Chinese University of Hong Kong 70Emory University 71Clinical Trial Overview of Emory University 71Karolinska Institutet 72Clinical Trial Overview of Karolinska Institutet 72Mount Sinai School of Medicine 73Clinical Trial Overview of Mount Sinai School of Medicine 73The University of Chicago 74Clinical Trial Overview of The University of Chicago 74Five Key Clinical Profiles 75Appendix 104Abbreviations 104Definitions 104Research Methodology 105Secondary Research 105About GlobalData 106Contact Us 106Disclaimer 106Source 107

List of Tables

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, North America, Top Countries, 2013* 14Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, BRIC Countries, 2013* 17Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, G7 Countries, 2013* 18Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, E7 Countries, 2013* 20Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Suspended Clinical Trials, 2013* 25Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 26Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Terminated Clinical Trials, 2013* 27Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 31Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 33Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2013* 35Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Genfit SA, 2013* 36Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 37Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Novo Nordisk A/S, 2013* 38Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 39Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Generex Biotechnology Corporation, 2013* 40Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Limerick BioPharma, Inc., 2013* 41Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by NuMe Health LLC, 2013* 42Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by KineMed, Inc., 2013* 43Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Arete Therapeutics Inc., 2013* 44Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by New Chapter, Inc., 2013* 45Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Cadila Pharmaceuticals Ltd., 2013* 46Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Resverlogix Corp., 2013* 47Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 48Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by UnitedHealth Group Incorporated, 2013* 49Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Marico Limited, 2013* 50Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 51Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2013* 52Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Bioneer Corporation, 2013* 53Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2013* 54Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Diabetes and Digestive and Kidney Diseases, 2013* 55Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2013* 56Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2013* 57Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2013* 58Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Eastern Finland, 2013* 59Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Maastricht University Medical Center, 2013* 60Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Leipzig, 2013* 61Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 62Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2013* 63Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Pennington Biomedical Research Foundation, 2013* 64Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 65Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Minnesota, 2013* 66Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 67Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013* 68Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2013* 69Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2013* 70Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2013* 71Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2013* 72Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by Mount Sinai School of Medicine, 2013* 73Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Chicago, 2013* 74

List of Figures

Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, G7 Countries (%), 2013* 18Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, E7 Countries (%), 2013* 20Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 29Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 30Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 32Pre-Diabetes/Impaired Glucose Tolerance Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 34GlobalData Methodology 105

To order this report:Drug_Discovery_and_Development Industry: Pre-Diabetes/Impaired Glucose Tolerance Global Clinical Trials Review, H2, 2013

Contact Clare: clare@reportlinker.com
US:(339) 368 6001
Intl:+1 339 368 6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.